These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

67 related articles for article (PubMed ID: 2391561)

  • 1. Successful rechallenge to etoposide after an acute vasomotor response.
    Tester WJ; Cohn JB; Fleekop PD; Rabinowitz MS; Lieberman JS
    J Clin Oncol; 1990 Sep; 8(9):1600-1. PubMed ID: 2391561
    [No Abstract]   [Full Text] [Related]  

  • 2. Outcomes of Platinum-Sensitive Small-Cell Lung Cancer Patients Treated With Platinum/Etoposide Rechallenge: A Multi-Institutional Retrospective Analysis.
    Genestreti G; Tiseo M; Kenmotsu H; Kazushige W; Di Battista M; Cavallo G; Carloni F; Bongiovanni A; Burgio MA; Casanova C; Metro G; Scarpi E; Korkmaz T; Selcuk S; Roopa K; Califano R
    Clin Lung Cancer; 2015 Nov; 16(6):e223-8. PubMed ID: 25983005
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Study on etoposide therapy of relapsing prostatic cancer patients].
    Moriyama M; Murai T; Kondoh I
    Hinyokika Kiyo; 1990 Jul; 36(7):777-81. PubMed ID: 2239575
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Acute hypotensive reaction to etoposide with successful rechallenge: case report and review of the literature.
    Cersosimo RJ; Calarese P; Karp DD
    DICP; 1989 Nov; 23(11):876-7. PubMed ID: 2688329
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Acute vasomotor response--a reaction to etoposide.
    Athanassiou AE; Bafaloukos D; Pectasidis D; Dimitriadis M
    J Clin Oncol; 1988 Jul; 6(7):1204-5. PubMed ID: 3079542
    [No Abstract]   [Full Text] [Related]  

  • 6. Low-dose oral etoposide: a new role for an old drug?
    Slevin ML
    J Clin Oncol; 1990 Oct; 8(10):1607-9. PubMed ID: 2170588
    [No Abstract]   [Full Text] [Related]  

  • 7. A phase I and translational study of sequential administration of the topoisomerase I and II inhibitors topotecan and etoposide.
    Hammond LA; Eckardt JR; Ganapathi R; Burris HA; Rodriguez GA; Eckhardt SG; Rothenberg ML; Weiss GR; Kuhn JG; Hodges S; Von Hoff DD; Rowinsky EK
    Clin Cancer Res; 1998 Jun; 4(6):1459-67. PubMed ID: 9626463
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Phase II study of etoposide (VP-16) in the form of oral capsules for malignant lymphomas].
    Konishi I; Kitani T; Nagai K; Kanamaru A; Kohsaki M; Masaoka T; Shibata H; Horiuchi A; Tsubaki K; Kawagoe H
    Gan To Kagaku Ryoho; 1985 Jul; 12(7):1482-6. PubMed ID: 4015122
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Acute myelomonocytic leukemia after treatment with chronic oral etoposide: are MLL and LTG9 genes targets for etoposide?
    Goto H; Shimazaki C; Tatsumi T; Yamagata N; Inaba T; Fujita N; Moriguchi T; Yamamoto K; Seto M; Ueda R
    Int J Hematol; 1994 Aug; 60(2):145-9. PubMed ID: 7948964
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A randomized trial of two etoposide schedules in small-cell lung cancer: the influence of pharmacokinetics on efficacy and toxicity.
    Clark PI; Slevin ML; Joel SP; Osborne RJ; Talbot DI; Johnson PW; Reznek R; Masud T; Gregory W; Wrigley PF
    J Clin Oncol; 1994 Jul; 12(7):1427-35. PubMed ID: 8021734
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prolonged administration of oral etoposide in patients with relapsed or refractory small-cell lung cancer: a phase II trial.
    Johnson DH; Greco FA; Strupp J; Hande KR; Hainsworth JD
    J Clin Oncol; 1990 Oct; 8(10):1613-7. PubMed ID: 2170589
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Successful chronic daily administration of oral etoposide for a case of adult T cell leukemia].
    Matsuoka H; Toyama T; Horinouchi M; Maeda K; Suzuki M; Kubuki Y; Komura K; Ishikawa T; Uno H; Tsubouchi H
    Gan To Kagaku Ryoho; 1993 Aug; 20(10):1387-90. PubMed ID: 8346938
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Secondary leukemia following high cumulative doses of etoposide in patients treated for advanced germ cell tumors.
    Kollmannsberger C; Beyer J; Droz JP; Harstrick A; Hartmann JT; Biron P; Fléchon A; Schöffski P; Kuczyk M; Schmoll HJ; Kanz L; Bokemeyer C
    J Clin Oncol; 1998 Oct; 16(10):3386-91. PubMed ID: 9779717
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [A phase II study of NK171 (etoposide)].
    Kimura K; Niitani H
    Gan To Kagaku Ryoho; 1985 Oct; 12(10):2011-7. PubMed ID: 2996442
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Pharmacokinetic aspects of oral administration of etoposide].
    Tillmann B; Krümpelmann S; Würthwein G; Wagner A; Schulze-Westhoff P; Hempel G; Jürgens H; Boos J
    Klin Padiatr; 1998; 210(4):159-64. PubMed ID: 9743946
    [TBL] [Abstract][Full Text] [Related]  

  • 16. VP-16-213. A phase II trial using a weekly schedule.
    Karp G; Antman K; Canellos G
    Cancer Clin Trials; 1981; 4(4):465-7. PubMed ID: 7318129
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Effect of daily administration of oral etoposide for non-small cell lung cancer treated with concurrent radiation therapy].
    Ohnishi H; Okada J; Yamaguchi M; Ogata H; Hatano K; Takizawa Y; Imai Y; Hara R; Araki T
    Nihon Igaku Hoshasen Gakkai Zasshi; 1997 Jul; 57(8):510-4. PubMed ID: 9267140
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Phase II evaluation of VP-16-213 in patients with advanced breast cancer: a Southwest Oncology Group Study.
    Vaughn CB; Panettiere F; Thigpen T; Bottomley R; Hoogstraten B; Samal B
    Cancer Treat Rep; 1981; 65(5-6):443-5. PubMed ID: 7237465
    [No Abstract]   [Full Text] [Related]  

  • 19. High dose intensity of cisplatin and etoposide in adenocarcinoma of unknown primary.
    Gill I; Guaglianone P; Grunberg SM; Scholz M; Muggia FM
    Anticancer Res; 1991; 11(3):1231-5. PubMed ID: 1888154
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Late phase II study with 21-consecutive-day oral administration of etoposide for malignant lymphoma].
    Yoshida T; Takagi T; Shimoyama M; Mikuni C; Suzuki K; Egami K; Furusawa S; Nomura T; Mori M; Sugimoto T
    Gan To Kagaku Ryoho; 1994 Dec; 21(16):2793-801. PubMed ID: 7993116
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.